Sr Associate Scientist, FPD
Gilead Sciences
Summary
We are seeking a highly motivated, attentive, and self-driven candidate to join our team, Biologics Pivotal & Commercial Formulation and Process Development, as an Sr. Associate Scientist. The successful candidate will contribute to the development of formulation and drug product processes for innovative molecules to support to advance medicines into the clinic. The candidate will have opportunities for career growth through acquisition of new skills, experiences, and professional relationships in a fast-paced and resource-rich environment. The ideal candidate is expected to be action oriented with high expectations of themselves and others and should possess good verbal and written communication and interpersonal skills.
Job description
Responsibilities
- Design and successfully execute experiments and activities to support formulation and drug process development, including formulation development, Drug Product manufacturing process development, and clinical in-use evaluations.
- Demonstrate understanding of analytical, biophysical characterization, and process development techniques; lead by example for lab executions.
- Clearly, timely, and accurately document data in appropriate repositories such as lab notebooks, reports, protocols, etc. following good documentation practices.
- Author technical documents such as protocols, reports, regulatory dossier, etc. and prepare data-focused presentations for internal and external audience.
- Effectively collaborate with both internal and external stakeholders in project meetings.
- Analyze data and draft conclusions before discussing with manager or supervisor.
- Support or represent function and work collaboratively on cross-functional teams to support project team strategy and regulatory filings.
- Fully embrace a lean-agile mindset, matrix working environment, and continuous improvement.
- Help support key project or department stakeholders as needed to ensure that company objects are met.
- Support team initiatives to drive business process excellence, scientific innovation, laboratory and work safety, etc.
Basic Qualifications
- MS/MA with 4+ years, or BS/BA with 6+ years of industrial experience in biologics CMC development.
- Hands-on laboratory experience required.
- Experience with formulation development, Drug Product process development, and clinical in-use evaluation for monoclonal antibodies, bispecifics, antibody-drug conjugates, fusion proteins, and other complex biologics formats strongly desired.
Requirements
- MS/MA with 4+ years, or BS/BA with 6+ years of industrial experience in biologics CMC development
- Hands-on laboratory experience required
- Experience with formulation development, Drug Product process development, and clinical in-use evaluation for monoclonal antibodies, bispecifics, antibody-drug conjugates, fusion proteins, and other complex biologics formats strongly desired
Benefits
- Medical insurance
- Dental insurance
- Vision insurance
- Life insurance
- Discretionary annual bonus
- Discretionary stock-based long-term incentives
- Paid time off
Company overview
Gilead Sciences, Inc. is a leading American biopharmaceutical company headquartered in Foster City, California, that specializes in researching, developing, and commercializing innovative medicines for life-threatening diseases. Founded in 1987, Gilead has grown into a global healthcare leader with approximately 17,600 employees worldwide. The company's primary therapeutic focus areas include HIV/AIDS, viral hepatitis (hepatitis B and C), oncology, inflammation, and respiratory diseases. Gilead is renowned for its groundbreaking antiviral therapies, including Sovaldi and Harvoni for hepatitis C, and its comprehensive portfolio of HIV treatments such as Truvada, Atripla, and Biktarvy. The company also developed Veklury (remdesivir) for COVID-19 treatment. Gilead operates as a publicly traded company on the NASDAQ (GILD) and is a component of both the Nasdaq-100 and S&P 100 indices. Through strategic acquisitions like Kite Pharma and Immunomedics, Gilead has expanded into cell therapy and oncology, demonstrating its commitment to advancing medical science and improving patient outcomes globally.